
60 sites needed. 76 delivered.
How AcceleTrial helped a large global pharma sponsor exceed site targets for a competitive Multiple Sclerosis trial. 50% of sites completed CDAs and Feasibility Questionnaires in under 7 days.
The Challenge
Site identification at scale
Identifying 60 sites (40 active, 20 backup) in a highly competitive Multiple Sclerosis therapeutic area.
Compressed document timelines
Executing CDAs and Feasibility Questionnaires with many clinical sites under an accelerated schedule.
Efficient site activation
Activating sites quickly and efficiently to meet or exceed the sponsor's targeted study timelines.
The Solution
Using AcceleTrial, LINEA identified 76 pre-qualified MS sites with specific expertise and patient access. 50% of sites completed both CDA and FQ in under 7 days. Rapid FQ turnaround enabled faster overall site selection.
Site Criteria
Outcomes
76 Sites Identified
Delivered against a target of 60, providing full activation cohort plus strong backup.
50% CDAs and FQs Under 7 Days
Half of all sites cleared both documents within 7 days, compressing the site selection cycle.
40 Sites Selected
Sponsor selected 40 sites from LINEA's delivery to date, meeting the activation target of 40.